Back to top
more

IDEXX Laboratories (IDXX)

(Real Time Quote from BATS)

$417.31 USD

417.31
268,596

-6.34 (-1.50%)

Updated Nov 15, 2024 01:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics

by Zacks Equity Research

The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Idexx Laboratories (IDXX) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Idexx (IDXX) delivered earnings and revenue surprises of 7.14% and 1.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

CVRx (CVRX) delivered earnings and revenue surprises of 3.51% and 9.41%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Will Alphatec (ATEC) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Philips' (PHG) Q1 Earnings Jump Y/Y on Strong Top-Line Growth

by Zacks Equity Research

Philips' (PHG) first-quarter results benefit from robust performances by the Diagnosis & Treatment and the Connected Care businesses.

Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should You Invest in the First Trust Water ETF (FIW)?

by Zacks Equity Research

Sector ETF report for FIW

Neogen (NEOG) New Buyouts Aid Growth Amid Rise in Expenses

by Zacks Equity Research

Neogen's (NEOG) performance of the Food Safety business is strong, driven by several long-term secular tailwinds.

AmerisourceBergen's (ABC) New JV to Boost Oncology Care

by Zacks Equity Research

AmerisourceBergen's (ABC) new JV is expected to provide the independent community oncology network with additional resources and expertise to grow the platform and improve patient outcomes.

IDEXX Laboratories (IDXX) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

IDEXX Laboratories' (IDXX) first-quarter 2023 results are expected to reflect an impressive performance in the CAG segment despite inflationary impacts.

Zimmer Biomet (ZBH) Hits 52-Week High: What's Driving It?

by Zacks Equity Research

Investors are optimistic about Zimmer Biomet's (ZBH) continued business recovery.

Masimo's (MASI) New FDA Approval to Improve Patient Monitoring

by Zacks Equity Research

Masimo's (MASI) receipt of the FDA's clearance for the Rad-G with Temperature is expected to support clinicians in almost any care scenario.

3 Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.

UnitedHealth (UNH) Buys Crystal Run to Boost Value-Based Care

by Zacks Equity Research

UnitedHealth Group (UNH) acquires Crystal Run, as per multiple reports. The move tends to offer enhanced value-based care across the Hudson Valley and lower Catskill region.

ALC vs. IDXX: Which Stock Is the Better Value Option?

by Zacks Equity Research

ALC vs. IDXX: Which Stock Is the Better Value Option?

Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now

by Zacks Equity Research

Investors are optimistic about IDEXX's (IDXX) strength in the Companion Animal Group business.

The Zacks Analyst Blog Highlights UnitedHealth Group, Salesforce, Linde, IDEXX and Telefonica

by Zacks Equity Research

UnitedHealth Group, Salesforce, Linde, IDEXX and Telefonica are included in this Analyst Blog.

Mark Vickery headshot

Top Research Reports for UnitedHealth Group, Salesforce & Linde

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Salesforce, Inc. (CRM) and Linde plc (LIN).

TMO or IDXX: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

TMO vs. IDXX: Which Stock Is the Better Value Option?

Why Is Idexx (IDXX) Down 6.6% Since Last Earnings Report?

by Zacks Equity Research

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now

by Zacks Equity Research

Investors are optimistic about IDEXX's (IDXX) strong global performance.

IDEXX (IDXX) Global Sales, Instrument Placement Robust

by Zacks Equity Research

IDEXX (IDXX) continues to demonstrate solid growth globally, primarily aided by a gain in CAG and Water businesses.

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

by Zacks Equity Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Zacks Industry Outlook Highlights Edwards Lifesciences, IDEXX Laboratories and Hologic

by Zacks Equity Research

Edwards Lifesciences, IDEXX Laboratories and Hologic have been highlighted in this Industry Outlook article.

Urmimala Biswas headshot

3 Medical Instruments Stocks to Buy Amid Improving Industry Trends

by Urmimala Biswas

The Zacks Medical - Instruments industry is growing on rising demand for digital health. EW, IDXX and HOLX are set to gain the most. Yet, the ongoing inflation, in the form of rising freight, raw material costs, is disrupting the trend.